BRAINSCAPES

The aim of BRAINSCAPES is to map in detail the biological mechanisms underlying multiple brain disorders ('brainscaping').

Recent genetic discovery studies have provided unprecedented insight into the genes involved in brain disorders. The next step is to use this knowledge for gaining mechanistic disease insight. In BRAINSCAPES we will develop novel analytic and experimental tools to study the functional consequences of risk genes on the function of specific cells, their circuits and functional output. We aim to provide insight into the molecular and cellular basis of complex brain disorders that can be used to design novel treatments.

News

December 1, 2025

Grants for BRAINSCAPES young researchers Wightman, Beerens and Kupke to advance memory-focused research on AD and PTSD

Recently three postdoctoral researchers from the Vrije Universiteit Amsterdam, and part of the BRAINSCAPES consortium, have received important funding. Alzheimer Nederland awarded €121,650 to Dr. Douglas Wightman (Complex Traits Genetics lab) to investigate genetic and environmental prediction of Alzheimer’s disease, while NWO awarded XS grants (€ 50,000) to both Dr. Sanne Beerens and Dr. Janina Kupke (Molecular and Cellular Neurobiology lab) to investigate how synapses on engram neurons (specific brain cells that store a memory) change to stabilize or modify memories. The three projects focus on advancing diagnostics and treatment of memory-related disorders, and build upon the work done in BRAINSCAPES.
Read More
April 9, 2025

Reward and Stress is orchestrated by small ensembles of neurons in the midbrain

How do small groups of neurons decide whether we approach a reward or avoid a threat? In a study published April 2nd 2025 in Nature Communications, Frank Meye’s lab at UMC Utrecht shows that distinct neuronal clusters (i.e. neuronal ensembles) in the ventral tegmental area (VTA) are essential for encoding positive and negative experiences.
Read More
March 13, 2025

Immune-developmental processes contribute to schizophrenia risk: insights from a genetic overlap study with height

In a study published in Biological Psychiatry, Cato Romero, Christiaan de Leeuw, Marijn Schipper, Bernardo Maciel, Martijn van den Heuvel, Rachel Brouwer, and Sophie van der Sluis from WP1 teamed up with colleagues Guus Smit and Frank Koopmans from WP3 to investigate why individuals diagnosed with schizophrenia tend to have shorter stature on average—a link first documented by Edward Burchard’s Physique and Psychosis nearly ninety years ago.
Read More
February 13, 2025

New AI tool helps to identify disease-related genes, boosting drug discovery

BRAINSCAPES scientists have developed a powerful new tool to pinpoint genes most likely causally linked to diseases, potentially accelerating drug development and advancing our understanding of disease biology. 
Read More
October 31, 2024 / our-news

Amsterdam UMC fellowship awarded to Dr. Danai Riga.

Recently BRAINSCAPES member Dr. Danai Riga was awarded the Amsterdam UMC fellowship. The fellowship (750K euro) will support here in establishing her independent research line and expand her research group. As of the first of November, Dr. Riga starts her new position as team leader within the Functional Genomics (FGA) group of the CNCR. With this her official involvement in BRAINSCAPES come to an end, although her future research will further build upon findings acquired in the project. We took the opportunity to congratulate Dr. Riga and ask her a few questions.
Read More
May 29, 2024

A chromatin-accessibility map of the human embryonic brain

Through a tightly organized cascade of patterning, specification and differentiation events, the human brain develops into a highly complex system capable of unique cognitive abilities beyond those of other mammals. Although gene expression across the developing brain has been described at single-cell resolution, similar atlases of chromatin accessibility have been primarily focused on the regulatory landscape of the developing human forebrain in the second-trimester of pregnancy. A collaboration between Marijn Schipper and Danielle Posthuma from CNCR-CTG and Camiel Mannens and Sten Linnarsson from the Karolinska Institute Sweden has opened a new window in creating the first map of chromatin accessibility and paired gene expression in the entire embryonic human brain in the first three months of development. The study is published May 1, 2024 in Nature.
Read More
January 25, 2024

About the strength of consortia (part 1)

On 12 December 2023 the Annual Amsterdam Neuroscience meeting took place at the RAI Amsterdam. In the afternoon a special session was dedicated to “Consortia at work”. Different “duos” involved in large consortia explained the strength and added value of these collaborative initiatives. In this first part we highlight the talk by Prof. dr. Huib Mansvelder and Prof. dr. Boudewijn Lelieveldt, two of the lead-PIs of BRAINSCAPES, who shared their experiences and involvement in the prestigious US Brain Initiative Cell Atlas Network (BICAN). This large-scale effort sees eleven different groups (and techniques) combined to develop cell atlases of the primate brain. In the past years BICAN’s predecessor has yielded its first important successes, and achieved things that no other single lab could do at this scale. Besides this, consortia help to extend networks and (importantly) are also just great fun! 
Read More
October 6, 2023

Single-cell reference mapping to construct and extend cell-type hierarchies

Single-cell RNA-sequencing is increasingly used to map the cellular heterogeneity of complex tissues. For example, more than 300 studies profiled a total of over 44 million cells across different brain regions, ages, and species. Since different research groups usually specialize in different cell-type compartments, these datasets usually differ in terminology and annotation depth. Our understanding of cellular diversity can be greatly enhanced by integrating these datasets to obtain a comprehensive atlas. In a recent publication, Lieke Michielsen, Marcel Reinders and Ahmed Mahfouz, in collaboration with the group of Fabian Theis (Helmholtz Centrum München), present ‘treeArches’, a framework to automatically build and update such reference atlases with a corresponding cell-type hierarchy. The atlas can be used to transfer cell annotations to new unlabeled datasets, facilitating reproducible analysis.
Read More
May 22, 2023

In the spotlight: interview with VICI recipient Dr. Ingo Willuhn

Recently, BRAINSCAPES PI Dr. Ingo Willuhn and his team were awarded an NWO VICI grant for their research into the function of serotonin and dopamine across brain regions. While there are already quite extensive insights into the individual action of these two neuromodulators, there is little understanding of the combined effects of these two systems on the brain. The VICI grant will allow Dr. Willuhn and his team to study interactive dopamine and serotonin signals in multiple brain regions. With this they aim to improve knowledge on the neurobiology of dysregulated behaviors, such as impulsivity which is a core symptom of several psychiatric disorders. Thus, ultimately, the findings may lead to the improved treatment of psychiatric disorders. Now that the good news has been received, Dr. Willuhn is organizing things to get started on the research. We have asked him a few questions on how things are going.
Read More
March 23, 2023

Similar but not the same: generating midbrain dopaminergic neuron heterogeneity during development

In their review recently published in Nature Reviews Neuroscience, Oxana Garritsen, Eljo van Battum, Laurens Grossouw and Jeroen Pasterkamp provide a comprehensive overview of the different molecular subsets and heterogeneity of dopaminergic neurons in the ventral midbrain of mice and humans. The authors first compare the currently defined subsets and then address molecular mechanisms that generate this diversity and that regulate subset positioning and target innervation in embryonic and early postnatal development. In addition, axonal wiring mechanisms and biological functions of dopaminergic neuron subtypes are extensively discussed. To further understand and treat diseases related to dopaminergic neurons, such as Parkinson disease, this review highlights the necessity of obtaining more extensive knowledge on midbrain dopamine neuron heterogeneity.
Read More